Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Leverage your Process Data using a Cloud-Based Collaboration Platform
26th May 2022 | 3:00 PM - 4:00 PM IST | Live Webinar
Novartis’s tislelizumab phase-III trial data shows survival results in esophageal cancer
First-line tislelizumab plus chemotherapy showed median Overall Survival (OS) of 17.2 months versus 10.6 months for chemotherapy…
Sanofi launches health brand with non-profit treatments for low-income countries
The treatments will be provided under the new Impact brand, part of Sanofi’s global health unit launched last year, which sits…
Antibody therapy less effective against new Omicron strains: Lancet
A team of researchers, including those from the German Primate Center (DPZ)-Leibniz Institute for Primate Research in Germany,…
Aurigene inks drug discovery, development pact with US-based EQRx
Under the terms of the collaboration agreement, Aurigene and EQRx will collaborate on drug discovery, pre-clinical and clinical…
Sigachi Industries ventures into human nutritional segment
The product portfolio will widely incorporate spray-dried ingredients, micronutrient premixes, encapsulated ingredients,…
Namitesh Roy Choudhury assumes role of Vice Chairman and Managing Director for LANXESS India region
In this new role, he will represent the businesses of LANXESS India to the global organisation
NITI Aayog releases compendium of AYUSH practices to manage COVID-19
In preparing the compendium, NITI Aayog reached out to all state governments and administrations of UTs, requesting them to share…
Novavax expects COVID vaccine targetting Omicron in fourth quarter
The company's vaccine, based on an earlier strain of the virus, has not yet been authorised in the US, and is currently under FDA…